Shelter Pharma Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
45.30 Cr.
|
P/BV
|
1.26
|
Book Value (Rs.)
|
30.98
|
52 Week High/Low (Rs.)
|
70/36
|
FV/ML
|
10/3000
|
P/E(X)
|
7.31
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
5.36
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 5.36 | 7.47 | 0.04 | 1.05 | 1.56 |
Diluted EPS (Rs.) | 5.36 | 7.47 | 0.04 | 1.05 | 1.56 |
Cash EPS (Rs.) | 5.58 | 7.68 | 41.85 | 3.45 | 4.46 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 30.17 | 17.52 | 162.47 | 128.93 | 132.36 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 30.98 | 18.74 | 181.93 | 148.39 | 155.16 |
Dividend / Share (Rs.) | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue From Operations / Share (Rs.) | 34.62 | 46.69 | 621.00 | 464.55 | 662.25 |
PBDIT / Share (Rs.) | 7.42 | 10.41 | 60.47 | 3.81 | 4.97 |
PBIT / Share (Rs.) | 7.21 | 10.20 | 56.98 | 1.42 | 2.07 |
PBT / Share (Rs.) | 7.17 | 10.18 | 56.83 | 1.42 | 2.07 |
Net Profit / Share (Rs.) | 5.36 | 7.47 | 38.37 | 1.05 | 1.56 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 21.42 | 22.29 | 9.73 | 0.82 | 0.75 |
PBIT Margin (%) | 20.81 | 21.83 | 9.17 | 0.30 | 0.31 |
PBT Margin (%) | 20.69 | 21.80 | 9.15 | 0.30 | 0.31 |
Net Profit Margin (%) | 15.49 | 15.99 | 6.17 | 0.22 | 0.23 |
Return on Networth / Equity (%) | 17.77 | 42.62 | 23.61 | 0.81 | 1.17 |
Return on Capital Employeed (%) | 22.85 | 52.07 | 31.31 | 0.93 | 1.30 |
Return On Assets (%) | 16.35 | 26.96 | 14.44 | 0.50 | 0.66 |
Long Term Debt / Equity (X) | 0.01 | 0.03 | 0.00 | 0.00 | 0.00 |
Total Debt / Equity (X) | 0.01 | 0.13 | 0.01 | 0.00 | 0.03 |
Asset Turnover Ratio (%) | 1.35 | 2.11 | 2.61 | 2.16 | 2.78 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 20.15 | 2.98 | 2.43 | 2.75 | 2.34 |
Quick Ratio (X) | 13.42 | 1.71 | 1.03 | 1.34 | 1.09 |
Inventory Turnover Ratio (X) | 3.23 | 3.86 | 5.52 | 5.05 | 6.43 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 184.02 | 579.84 | 408.62 | 0.00 | 0.00 |
Interest Coverage Ratio (Post Tax) (%) | 134.05 | 417.06 | 260.28 | 0.00 | 0.00 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 52.38 | 0.00 | 0.00 | 0.00 | 0.00 |
EV / Net Operating Revenue (X) | 1.31 | 0.00 | 0.00 | 0.00 | 0.00 |
EV / EBITDA (X) | 6.11 | 0.00 | 0.00 | 0.00 | 0.00 |
MarketCap / Net Operating Revenue (X) | 1.42 | 0.00 | 0.00 | 0.00 | 0.00 |
Price / BV (X) | 1.63 | 0.00 | 0.00 | 0.00 | 0.00 |
Price / Net Operating Revenue (X) | 1.42 | 0.00 | 0.00 | 0.00 | 0.00 |
EarningsYield | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 |